GliaCure Closes on $5.8 Million Financing

August 4, 2014

B round financing with new and existing investors will advance GliaCure’s Alzheimer’s clinical program

GliaCure, Inc., a company focused on developing novel, non-neuronal therapies for a range of neurological and neuropsychiatric disorders, today announced that it has successfully completed a $5.8 million B round financing, exceeding its original goal of $5 million. This financing round is incremental to its initial A round financing of $2.75 million in 2012 and includes both existing and new investors.

mso-hansi-theme-font: major-latin;"> GliaCure director Walter Dewey said, “We are very excited to have exceeded our fundraising goal. We believe this financing demonstrates the deep commitment of our existing investors and the confidence new investors have in GliaCure’s Alzheimer’s disease drug development program. We are extremely grateful to all who have chosen to join the GliaCure adventure and look forward to deploying this capital to advance the company’s upcoming Phase 1 clinical trial in Alzheimer’s disease.”

mso-hansi-theme-font: major-latin;"> “This level of funding from a network of private investors and high net worth individuals is truly exceptional,” said Phil Haydon, Ph.D., President and co-Founder of GliaCure. “It will allow us to push forward aggressively with our development program, particularly in Alzheimer’s disease. We are confident that we will justify the trust that our investors have placed in us.”

For more information, visit their website.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.